NIH supports small businesses moving funded research toward commercialization through later-stage development, clinical studies, manufacturing scale-up, and specialized technical assistance.
Funder: National Institutes of Health
Due Dates: January 5, 2027 (Application) | April 5, 2027 (Application) | September 5, 2027 (Application) | January 5, 2028 (Application) | April 5, 2028 (Application) | September 5, 2028 (Application) | January 5, 2029 (Application) | April 5, 2029 (Application)
Funding Amounts: Component guidelines of $500,000, $2,000,000, or the SBA CRP limit; maximum 3 years; no cost sharing
Summary: Supports late-stage development and technical assistance to move NIH-funded SBIR/STTR technologies toward commercialization.
Key Information: Only U.S. small businesses with qualifying NIH Phase II or Phase IIB funding within the last 36 months may apply; one CRP award per project.
The NIH Commercialization Readiness Pilot (CRP) program provides additional support to small businesses advancing NIH-funded SBIR or STTR projects toward commercialization. It funds later-stage research and development, technical assistance, or both, including activities not typically supported by Phase II or Phase IIB Strategic Breakthrough awards. Projects must align with a participating NIH Institute, Center, or Office’s mission.
Supported work includes independent confirmation of key studies, IND- or IDE-enabling studies, clinical studies, manufacturing development and scale-up, quality systems activities, regulatory strategy, intellectual property strategy, and market research. Businesses may outsource a significant portion of the work while retaining substantive scientific, programmatic, financial, and administrative oversight. Clinical trials are optional, but several participating components do not accept them through this opportunity.